Early Testing
At Risk for T1D Clinic
We care for patients at high risk of developing type 1 diabetes (T1D). By detecting early signs of T1D and taking proactive measures, we can slow its progression and delay the need for insulin therapy. If your child is at risk for T1D, whether due to family history or a positive autoantibody test, early detection is key. Treatments, such as the immune therapy teplizumab (Tzield), can slow T1D progression, giving patients more time before needing to start insulin therapy. If you have concerns about type 1 diabetes risk, contact us as soon as possible. Early detection can make a lasting difference in your child's health.